Kidney Trials


Trial No.: TRIO-US CA209-9ER

Trial Name:

A Phase 3, Randomized, Open-Label Study of Cabozantinib Combined with Nivolumab Alone or Cabozantinib Combined with Nivolumab and Ipilimumab versus Sunitinib in Patients with Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma

Fort Wayne North Office
(260) 484-8830
11143 Parkview Plaza Drive, Suite 100
Fort Wayne, Indiana 46845

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.